Recombinant adeno-associated viruses (rAAVs) have emerged as one of the most promising gene therapy vectors that have been successfully used in pre-clinical models of heart disease. However. this has not translated well to humans due to species differences in rAAV transduction efficiency. As a result. https://www.elphonsolam.com/product-category/canvas/